easy-sep® human whole blood cd66b positive selection kit (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
easy-sep® human whole blood cd66b positive selection kit
Easy Sep® Human Whole Blood Cd66b Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easy-sep%C2%AE+human+whole+blood+cd66b+positive+selection+kit/pe+conjugated+cd66b+antibody/10__1160_slash_th14___06___0549-68-10-18
Average 90 stars, based on 1 article reviews
Easy Sep® Human Whole Blood Cd66b Positive Selection Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easy-sep%C2%AE+human+whole+blood+cd66b+positive+selection+kit/pe+conjugated+cd66b+antibody/10__1160_slash_th14___06___0549-68-10-18
Average 90 stars, based on 1 article reviews
easy-sep® human whole blood cd66b positive selection kit - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Isolation:Article Title: Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro Article Snippet: Konstantin A. Krychtiuk1,2; Lukas Watzke1; Christoph Kaun1; Elisabeth Buchberger3; Renate Hofer-Warbinek4; Svitlana Demyanets1; Julia Pisoni1,2; Stefan P. Kastl1; Sabine Rauscher5,6; Marion Gröger5,6; Arezu Aliabadi3; Andreas Zuckermann3; Gerald Maurer1; Rainer de Martin4; Kurt Huber2,7; Johann Wojta1,2,6; Walter S. Speidl1 1Department of Internal Medicine II, Medical University of Vienna, Austria; 2Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria; 3Department of Surgery, Medical University of Vienna, Austria; 4Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria; 5Skin and Endothelium Research Division (SERD), Department of Dermatology, Medical University of Vienna; 6Core Facilities, Medical University of Vienna, Austria; 73rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria Selection:Article Title: Levosimendan exerts anti-inflammatory effects on cardiac myocytes and endothelial cells in vitro Article Snippet: Konstantin A. Krychtiuk1,2; Lukas Watzke1; Christoph Kaun1; Elisabeth Buchberger3; Renate Hofer-Warbinek4; Svitlana Demyanets1; Julia Pisoni1,2; Stefan P. Kastl1; Sabine Rauscher5,6; Marion Gröger5,6; Arezu Aliabadi3; Andreas Zuckermann3; Gerald Maurer1; Rainer de Martin4; Kurt Huber2,7; Johann Wojta1,2,6; Walter S. Speidl1 1Department of Internal Medicine II, Medical University of Vienna, Austria; 2Ludwig Boltzmann Cluster for Cardiovascular Research, Vienna, Austria; 3Department of Surgery, Medical University of Vienna, Austria; 4Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Austria; 5Skin and Endothelium Research Division (SERD), Department of Dermatology, Medical University of Vienna; 6Core Facilities, Medical University of Vienna, Austria; 73rd Medical Department for Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria |